Premature Ejaculation in Men: Symptoms, Causes and Treatment

• Explains how premature ejaculation is identified rather than relying on timing alone
• Distinguishes persistent symptoms from occasional early ejaculation
• Covers possible contributing factors and overlapping erection difficulties
• Explains why treatment should follow individual clinical assessment

Premature ejaculation (PE) is a common and treatable condition in which ejaculation repeatedly happens sooner than desired during intimate activity, together with difficulty controlling it and meaningful personal impact. A single early episode does not by itself establish a premature ejaculation problem because diagnosis considers the wider pattern rather than one isolated event.

NICE's evidence summary for dapoxetine uses defined criteria when describing adults for whom the licensed treatment is intended. These include persistent or recurrent symptoms, poor control and meaningful personal consequences. This supports a broader clinical approach rather than deciding that someone has premature ejaculation pe solely from a stopwatch measurement.

Key things to know

• Premature ejaculation involves more than timing alone.
• Poor control and a persistent pattern are important parts of assessment.
• Occasional early ejaculation does not automatically establish a disorder.
• Symptoms may be longstanding or may develop after a period of different control.
• Erectile dysfunction can occur alongside premature ejaculation.
• Medical, psychological and medicine-related factors may be relevant to assessment.
• Dapoxetine is specifically licensed in the UK for premature ejaculation in eligible adults.
• Prescription treatment requires appropriate clinical assessment.
• Current medicines matter because interactions and contraindications may affect suitability.
• Results from treatment vary between individuals.

What Is Premature Ejaculation?

Premature ejaculation is characterised by recurrent ejaculation sooner than wanted combined with difficulty controlling the process. The condition should be considered in terms of persistence, control and personal impact rather than defining every early episode as a medical problem.

NICE's dapoxetine evidence summary describes premature ejaculation as involving short ejaculatory latency, poor control and negative personal consequences within the medicine's licensed criteria. This distinction prevents normal variation from automatically being medicalised.

What Are the Main Signs of Premature Ejaculation?

The main signs and symptoms of premature ejaculation are a recurring pattern of ejaculation occurring sooner than wanted, limited ability to control it and meaningful concern or frustration associated with the pattern. Symptoms need to be considered together because timing alone provides an incomplete picture.

Someone who experiences occasional variation without an ongoing pattern should therefore not assume that they necessarily have the condition, as occasional episodes are common and do not necessarily indicate a disorder.

Is Premature Ejaculation Just About How Long Ejaculation Takes?

No. Timing is relevant, but it is not the only factor. A meaningful assessment also considers whether ejaculation can be controlled, how consistently the problem occurs and whether it causes significant personal difficulty.

NICE's licensed criteria for dapoxetine illustrate this multi-factor approach by combining timing with poor control, persistence and personal impact. For example, intravaginal ejaculation latency time may sometimes be used clinically as one measure, but a single numerical threshold should not be used in isolation as a self-diagnosis tool.

Start Your Free Assessment

Are There Different Types of Premature Ejaculation?

Premature ejaculation can broadly be classified into lifelong and acquired types, with the longstanding pattern described as primary premature ejaculation and a later-developed pattern described as acquired premature ejaculation. Distinguishing between these patterns is clinically useful because a newly developed change may prompt consideration of contributing health, medicine or psychological factors.

A useful assessment asks when the problem began, whether it has always been present and whether another change occurred around the same period. The history can provide more information than focusing only on what happens during the most recent episode, and acquired or secondary premature ejaculation can prompt review of psychological, physical, or medicine-related triggers.

What Can Cause a Premature Ejaculation Problem?

There is not one universal cause of premature ejaculation. Biological processes, including neurotransmitter imbalance and possible genetic factors, psychological factors, other health conditions and the presence of another erection-related problem can all potentially influence the clinical picture, and premature ejaculation may also reflect psychological factors such as anxiety and stress.

This is why treatment should not begin with the assumption that every person has the same underlying mechanism. A structured assessment can consider symptom history, current medicines, relevant medical conditions, emotional factors and whether another problem appeared before or alongside the ejaculation difficulty, as people may experience premature ejaculation for different reasons, including in some cases prostate inflammation or alcohol and drug misuse.

Can Worry and Performance Anxiety Affect Premature Ejaculation?

Worry, anticipatory concern, pressure and performance anxiety can influence control in some people, particularly when repeated difficulties create an expectation that the problem will happen again. This does not mean every case is psychological or that physical contributing factors can be ignored.

The practical approach is to consider the whole pattern. If symptoms are persistent, newly developed, or accompanied by another health change, assessment can help identify whether psychological factors, physical factors, or a combination may be relevant, as repeated worry can affect arousal and contribute to a sense of reduced control.

Can Erectile Dysfunction Occur With Premature Ejaculation?

Yes. Erectile dysfunction and premature ejaculation can occur in the same person, although they are different conditions. Erectile dysfunction primarily concerns difficulty obtaining or maintaining an erection, whereas premature ejaculation primarily concerns ejaculation control.

NICE's dapoxetine evidence summary recognises the coexistence of premature ejaculation and erectile dysfunction. When both occur, identifying which problem began first and how they interact can influence the clinical approach rather than assuming that one medicine should treat both.

Can Medicines Contribute to a Change in Ejaculation?

Medicines can sometimes be relevant when a new symptom pattern appears, which is why a complete medication history forms a useful part of assessment. Prescription treatments, recently started medicines and changes to existing treatment should be disclosed rather than altered independently.

The MHRA explains that prescription-only status is used where professional supervision may be necessary because of risks from incorrect use, possible side effects or the need for appropriate diagnosis. Do not stop another prescribed medicine simply because symptoms appeared after treatment started.

Start Your Free Assessment

When Does Premature Ejaculation Become a Persistent Problem?

A premature ejaculation problem becomes more clinically relevant when the pattern is recurrent, difficult to control and causes meaningful concern rather than occurring only occasionally. Persistence over time provides more useful information than one unusually early episode.

A simple assessment framework is:

• Is the problem recurring rather than isolated?
• Is control consistently difficult?
• Has the pattern persisted over time?
• Has there been a noticeable change from previous control?
• Is another erection problem also present?
• Did symptoms change after starting another medicine?
• Is the problem causing meaningful concern?

Persistent symptoms, or cases where you suddenly experience premature ejaculation, should be discussed with a GP.

These questions do not provide a diagnosis by themselves, but they help establish whether professional assessment may be useful.

How Is Premature Ejaculation Assessed?

Assessment is mainly how premature ejaculation is diagnosed in practice: from a clear symptom pattern and intimate history rather than a single test. The clinician needs to understand when symptoms started, how consistently they occur, the degree of control, whether it happens with minimal stimulation or reflects a recent change from the previous pattern, and whether another health or erection-related difficulty or other ejaculation problems are present.

A useful assessment can also review current medicines and medical history. This prevents treatment from being selected solely because a particular medicine is familiar and helps identify contraindications or interactions before prescription treatment is considered.

Is There a Medicine Licensed Specifically for Premature Ejaculation?

Yes. NICE identifies dapoxetine, a short-acting selective serotonin reuptake inhibitor, as the first pharmacological treatment specifically licensed in the UK for premature ejaculation. Its evidence summary reports statistically significant improvements in measured outcomes compared with placebo in pooled randomised controlled trials, while also recognising adverse effects and limitations in the evidence.

This does not mean dapoxetine is appropriate for everyone with early ejaculation. The licensed indication uses defined clinical criteria, and contraindications, medicine interactions and individual benefit-risk considerations must be assessed before prescribing.

Why Should Treatment Follow a Clinical Assessment?

Treatment should follow assessment because premature ejaculation can have different patterns and contributing factors. The most appropriate approach for a longstanding problem may differ from the approach to a newly developed change or symptoms occurring alongside erectile dysfunction.

Prescription medicine also requires appropriate professional oversight. MHRA guidance explains that prescription-only medicines can only be obtained with a valid prescription from an authorised health professional. The goal is therefore to match treatment to the individual problem rather than simply suppressing a symptom.

Start Your Free Assessment

What Treatment Options May Be Considered for Premature Ejaculation?

Premature ejaculation is a common and treatable condition, and management depends on the symptom pattern, possible contributing factors and individual clinical circumstances. Management may involve addressing contributing problems, psychological approaches, behavioural strategies or medicine where clinically appropriate; behavioural therapy is a common first-line option to treat premature ejaculation, and counselling may help when anxiety or relationship stress contributes. There is no single treatment that produces the same outcome for everyone.

Where prescription medicine is considered, suitability should be assessed rather than assumed. NICE identifies dapoxetine as specifically licensed in the UK for premature ejaculation in eligible adults, while other approaches may have different evidence or licensing positions; SSRIs can delay ejaculation and are often prescribed, topical anesthetics can reduce sensitivity to delay ejaculation, and sildenafil may help with premature ejaculation in some cases depending on the clinical picture. Treatment choice should therefore reflect diagnosis, safety and individual circumstances.

What Is the Role of Dapoxetine?

Dapoxetine is a short-acting selective serotonin reuptake inhibitor with a specific UK indication for premature ejaculation in adults who meet defined criteria. NICE's evidence summary reports that randomised controlled trials found statistically significant improvements in relevant outcomes compared with placebo, while also documenting adverse effects and limitations in the evidence.

Dapoxetine is not appropriate for everyone. Medical history, current medicines, contraindications and previous reactions can affect suitability. Treatment should only be used under the supervision of an appropriately qualified prescriber, and results vary between individuals.

What Non-Medicine Approaches May Be Considered?

Non-medicine management can be relevant, particularly when worry, learned responses or other psychological factors contribute to the problem. The appropriate approach depends on the individual's symptom history and whether another condition is present.

A clinical management plan may consider:

• behavioural therapy using practical methods such as the stop-go technique and the squeeze technique to help delay ejaculation, with the method involving squeezing the penis just before ejaculation to reduce arousal
• Counselling or therapy where worry, pressure, emotional concerns, or underlying psychological issues are important, and couples therapy may help with communication, intimacy, and relationship concerns.
• management of contributing health factors
• review of medicines that may influence symptoms
• treatment of a coexisting erection problem where clinically appropriate, while some self-help strategies, such as masturbating before intercourse, and Kegel exercises may help some individuals improve control

These approaches should not be presented as guaranteed cures. Different people may require different combinations of management strategies.

Can Premature Ejaculation Go Away Without Medicine?

Symptoms may change over time in some people, particularly where a temporary contributing factor is involved, but persistent premature ejaculation should not be assumed to disappear automatically. A newly developed problem may also warrant assessment to identify what changed around the time symptoms began.

The useful distinction is between occasional variation and a recurring pattern involving poor control and meaningful concern. Where symptoms continue, assessment can help determine whether management is needed rather than repeatedly trying unverified remedies.

Can Lifestyle Changes Help Premature Ejaculation?

General health measures can support overall wellbeing, but lifestyle changes should not be promoted as a guaranteed treatment for premature ejaculation. Their relevance depends partly on whether another health condition, emotional factor or erection problem contributes to the symptoms.

A balanced approach avoids claims that one food, vitamin, exercise routine or lifestyle change will reliably resolve the condition. Where a specific deficiency or underlying condition is suspected, it should be assessed on its own clinical merits rather than assumed to be the universal cause.

Start Your Free Assessment

Can Erectile Dysfunction Change the Treatment Approach?

Yes. When erectile dysfunction occurs alongside premature ejaculation, the relationship between the two conditions may influence management. An erection problem can alter the wider symptom pattern, so treating only the ejaculation difficulty may not address everything that is contributing.

A useful comparison is:

This is why the timeline of symptoms can provide important information.

Should Erectile Dysfunction Medicines Be Used for Premature Ejaculation?

Medicines used for erectile dysfunction should not automatically be treated as dedicated premature-ejaculation treatments. Sildenafil and tadalafil are PDE5 inhibitors with established roles for erectile dysfunction, while dapoxetine has a specific UK indication for premature ejaculation.

When both conditions are present, medicine selection becomes more complex. Do not independently combine prescription treatments, because interactions and contraindications may apply. A prescriber should determine which problem requires treatment and whether the proposed medicine is appropriate.

Can Dapoxetine Be Combined With Other Treatments?

Prescription medicines should not be combined independently in an attempt to achieve a stronger result. NICE's dapoxetine evidence summary identifies important interaction considerations and states that dapoxetine should not be used in people taking PDE5 inhibitors because of increased syncope risk.

Syncope means temporary loss of consciousness or fainting. This demonstrates why combining medicines based on their separate uses can create a different safety profile from using either medicine individually.

What Side Effects Can Occur With Dapoxetine?

Dapoxetine can cause adverse effects, so expected benefit must be balanced against tolerability. NICE identifies nausea, dizziness and headache among the very commonly reported adverse reactions in its evidence summary.

The practical safety approach is to distinguish mild, temporary symptoms from significant or concerning reactions. Persistent adverse effects should be discussed with an appropriate healthcare professional, while serious or rapidly worsening symptoms require medical attention appropriate to their severity. As with certain medications and other medicines used around intimate activity, prescribed topical anaesthetics can reduce sensitivity to delay ejaculation, and local anaesthetic creams are typically applied 20–60 minutes beforehand.

Why Do Current Medicines Matter?

Current medicines can affect treatment suitability because clinically important interactions may occur. A treatment used for an apparently unrelated condition can still matter when a prescriber assesses premature ejaculation.

Before treatment assessment, provide an accurate list of:

• prescription medicines;
• relevant non-prescription medicines;
• recently stopped treatments;
• previous important medicine reactions; and
• any recent changes to regular medication.

Do not stop another prescribed medicine simply to try to become eligible for a particular premature-ejaculation treatment.

What if Treatment Does Not Work as Expected?

A limited response does not mean that medicine should automatically be increased, switched or combined with another treatment. Results vary between individuals, and a treatment that is appropriate for one person may provide less benefit for another.

A review can consider whether the original diagnosis remains appropriate, whether meaningful improvement occurred, whether adverse effects developed and whether another contributing factor has been overlooked. This provides a safer pathway than independently changing treatment.

How Should Treatment Progress Be Reviewed?

Treatment progress should be reviewed using more than a single timing measurement. Control, consistency, personal impact, tolerability and changes in other symptoms can all provide useful information.

This broader review helps avoid judging treatment solely by one numerical result.

When Should Premature Ejaculation Be Assessed?

Assessment is reasonable when the problem is persistent, difficult to control, causes meaningful concern during intimate activity, or represents a substantial change from the person's previous pattern, and these features should be discussed with a GP or appropriate clinician. Newly developed symptoms can be particularly useful to discuss because another factor may have changed.

Clinical assessment is also relevant when premature ejaculation occurs alongside erection difficulty, new medicine use or another health concern. The aim is not simply to label the symptom but to understand the pattern and identify an appropriate management approach.

Can Premature Ejaculation Be Permanently Cured?

A permanent cure should not be promised. Premature ejaculation can have different patterns and contributing factors, so treatment outcomes vary and management may focus on improving control and reducing the impact of symptoms rather than guaranteeing permanent elimination.

Claims of universal or permanent results should therefore be treated cautiously. A more useful goal is to identify contributing factors, establish whether treatment is appropriate and review whether the chosen management approach provides meaningful benefit.

What Is the Practical Approach to a Premature Ejaculation Problem?

Start by establishing whether the problem is occasional or persistent. A recurring pattern involving poor control and meaningful concern that affects intimate experiences or contributes to relationship issues is more clinically relevant than an isolated early episode.

The practical pathway is:

1. describe the symptom pattern accurately
2. identify when the problem began, including whether it appears lifelong or acquired;
3. mention any erection difficulties
4. provide current medicine and medical information
5. allow an appropriately qualified professional to assess contributing factors, including any relationship problems or past intimate experiences
6. review treatment benefit and tolerability if management is started.

This approach focuses on the individual problem rather than assuming that every case has the same cause, requires the same treatment, or affects every intimate relationship in the same way.

Medical Disclaimer

Changes in ejaculation control can have different explanations, and information about typical patterns cannot establish the cause for an individual. A persistent problem, a substantial change from previous control or symptoms occurring alongside another health concern may require appropriate assessment.

This guide is intended to explain premature ejaculation and the principles used when considering management. It does not provide an individual diagnosis or instructions for starting, stopping, changing or combining prescription medicines. Treatment decisions should be based on current medical information and assessment by an appropriately qualified prescriber.